Advisors Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-836
Closed -$8.69K 1480
2024
Q3
$8.69K Sell
836
-153
-15% -$2.54K ﹤0.01% 1414
2024
Q2
$19.5K Hold
989
﹤0.01% 1365
2024
Q1
$25.3K Sell
989
-48
-5% -$1.23K ﹤0.01% 1350
2023
Q4
$28.6K Buy
1,037
+30
+3% +$1.83K ﹤0.01% 1333
2023
Q3
$61.2K Sell
1,007
-2
-0.2% -$140 ﹤0.01% 1256
2023
Q2
$66.4K Sell
1,009
-26
-3% -$1.9K ﹤0.01% 1250
2023
Q1
$65.8K Buy
1,035
+165
+19% +$18.8K ﹤0.01% 1271
2022
Q4
$120K Buy
+870
New +$123K ﹤0.01% 1213
2021
Q1
Sell
-232
Closed -$130K 1487
2020
Q4
$130K Sell
232
-2
-0.9% -$1.27K ﹤0.01% 1316
2020
Q3
$164K Sell
234
-4
-2% -$3.12K ﹤0.01% 1223
2020
Q2
$189K Sell
238
-3
-1% -$2.26K ﹤0.01% 1183
2020
Q1
$143K Sell
241
-98
-29% -$95.5K ﹤0.01% 1167
2019
Q4
$385K Sell
339
-76
-18% -$82.6K 0.01% 1060
2019
Q3
$494K Sell
415
-244
-37% -$373K 0.01% 978
2019
Q2
$1.08M Sell
659
-68
-9% -$118K 0.02% 752
2019
Q1
$1.48M Sell
727
-210
-22% -$370K 0.03% 676
2018
Q4
$1.2M Sell
937
-155
-14% -$238K 0.02% 694
2018
Q3
$2.07M Buy
1,092
+27
+3% +$55.8K 0.03% 594
2018
Q2
$2.17M Sell
1,065
-302
-22% -$688K 0.04% 577
2018
Q1
$3.56M Buy
1,367
+3
+0.2% +$7.63K 0.06% 421
2017
Q4
$3.15M Buy
1,364
+80
+6% +$162K 0.05% 472
2017
Q3
$2.29M Buy
1,284
+288
+29% +$402K 0.04% 575
2017
Q2
$1.36M Buy
996
+267
+37% +$322K 0.02% 760
2017
Q1
$858K Buy
+729
New +$744K 0.01% 912

Other funds holding BLUE

Advisors Asset Management's BLUE Position: Q4 2024 in Review

Advisors Asset Management sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 836 shares — an estimated $8.69K sold.

Advisors Asset Management first reported a position in BLUE in Q1 2017 and held it in 24 quarters. The position peaked at $3.56M in Q1 2018. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Advisors Asset Management reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Advisors Asset Management sold 836 bluebird bio shares in Q4 2024, an estimated $8.69K.
  • Advisors Asset Management first reported a position in bluebird bio in Q1 2017 and held it in 24 quarters.
  • Advisors Asset Management's bluebird bio position peaked at $3.56M in Q1 2018.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Advisors Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.